Dr. Martens PLC

AGM Information • Jul 11, 2024

National Storage Mechanism | Additional information

RNS Number : 0617W

Dr. Martens PLC

11 July 2024

11 July 2024

DR. MARTENS PLC

RESULT OF ANNUAL GENERAL MEETING

11 JULY 2024

The Company announces the results of voting at its Annual General Meeting held earlier today and confirms that all resolutions were duly passed on a poll with majorities as set out below.

Resolutions 1 to 16 were proposed as Ordinary Resolutions and resolutions 17 to 20 as Special Resolutions.

Resolution		Votes For (note 1)	%	Votes Against (note 1)	%	Votes Total	Votes Withheld (note 2)	% Voting Capital Instructed
01	Receive the 2024 Annual Report and Accounts	789,653,948	99.87%	1,016,107	0.13%	790,670,055	389,119	82.18
02	Approve the Directors' Remuneration Report	784,551,256	99.18%	6,479,754	0.82%	791,031,010	28,164	82.22
03	Approve the Remuneration Policy	784,540,438	99.18%	6,484,634	0.82%	791,025,072	34,102	82.22
04	Approve the Final Dividend	790,899,254	99.98%	138,398	0.02%	791,037,652	21,522	82.22
05	Elect Giles Wilson	790,575,687	99.94%	472,252	0.06%	791,047,939	11,235	82.22
06	Re-elect Paul Mason	739,380,746	98.45%	11,649,105	1.55%	751,029,851	40,029,322	78.06
07	Re-elect Kenny Wilson	782,546,350	99.38%	4,857,639	0.62%	787,403,989	3,655,185	81.84
08	Re-elect Andrew Harrison	784,035,245	99.11%	7,011,325	0.89%	791,046,586	12,587	82.22
09	Re-elect Ian Rogers	784,033,188	99.11%	7,013,122	0.89%	791,046,586	12,587	82.22
10	Re-elect Lynne Weedall	782,969,980	98.98%	8,079,606	1.02%	791,049,586	9,587	82.22
11	Re-elect Robyn Perriss	783,169,527	99.00%	7,880,059	1.00%	791,049,586	9,587	82.22
12	Re-elect Tara Alhadeff	775,890,657	98.53%	11,583,929	1.47%	787,474,586	3,584,587	81.85
13	Re-appoint PricewaterhouseCoopers LLP as auditor	790,431,574	99.92%	619,491	0.08%	791,051,065	8,109	82.22
14	Authorise the Audit & Risk Committee to determine the Auditor's remuneration	790,886,095	99.98%	160,465	0.02%	791,046,560	12,614	82.22
15	Authorise the Company and its subsidiaries to make political donations	782,418,912	99.36%	5,046,388	0.64%	787,465,300	3,593,874	81.85
16	Authorise allotment of shares	781,095,005	99.30%	5,488,607	0.70%	786,583,612	4,475,562	81.76
17	Authorise general disapplication of pre-emption rights*	744,775,869	94.58%	42,685,045	5.42%	787,460,914	3,598,260	81.85
18	Authorise additional disapplication of pre-emption rights*	743,752,064	94.45%	43,708,850	5.55%	787,460,914	3,598,260	81.85
19	Authorise purchase of own shares*	772,052,557	97.61%	18,934,341	2.39%	790,986,898	72,276	82.22
20	Authorise calling of general meetings on 14 days' notice*	788,373,014	99.66%	2,680,102	0.34%	791,053,116	6,058	82.22

*Special Resolution

The votes of independent shareholders on the resolutions concerning the election or re-election of the Independent Non-Executive Directors are set out below:

Resolution		Votes For	%	Votes Against	%	Votes Total	Votes Withheld	% Independent Capital Instructed
08	Re-elect Andrew Harrison	414,092,821	98.34%	7,011,325	1.66%	421,104,146	12,587	71.12%
09	Re-elect Ian Rogers	414,091,024	98.33%	7,013,122	1.67%	421,104,146	12,587	71.12%
10	Re-elect Lynne Weedall	413,027,540	98.08%	8,079,606	1.92%	421,107,146	9,587	71.13%
11	Re-elect Robyn Perriss	413,227,087	98.13%	7,880,059	1.87%	421,107,146	9,587	71.13%

Notes:

1.     Votes "For" and "Against" are expressed as a percentage of votes received.

2.    A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

3.    As at 6.30pm on 9 July 2024 the Company had a total of 962,080,090 ordinary shares with voting rights in issue. The total independent voting capital, used to calculate the votes of independent shareholders on resolutions 8 to 11, was 592,062,882.

4.     In accordance with Listing Rule 9.6.2R, copies of the resolutions passed as special business will shortly be available for inspection on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .  

Enquiries

Company Secretariat

Paul Rolling, Assistant Company Secretary                                                                   +44 7584 243562

Investors and analysts                                                                     

Bethany Barnes, Director of Investor Relations                                                             +44 7825 187465

bethany.barnes@drmartens.com

Media                                                                                                                                                  

Gill Hammond, Director of Communications                                                                +44 7384 214248

H/Advisors Maitland                                                                                                      +44 20 7379 5151

Katharine Spence                                                                                                            +44 7384 535739                               

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Produced originally for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens has since transcended its working-class roots while still celebrating its proud heritage and, six decades later, "Docs" or "DM's" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company is a constituent of the FTSE 250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGGPUCUMUPCGUG